Switch to:
More From Other Websites
AstraZeneca's Regulatory Filing for Lesinurad Accepted - Analyst Blog Jan 26 2015
2:25 am Roche Hldg receives FDA clearance for next generation cobas MRSA/SA Test Jan 26 2015
Roche receives FDA clearance for next generation cobas MRSA/SA Test Jan 26 2015
Putting the spotlight on Illumina Jan 23 2015
Curis Up on Immuno-Oncology Agreement with Aurigene - Analyst Blog Jan 22 2015
Investment Bets On Antibiotics To Help Invigorate Investor Portfolios Jan 21 2015
Ventana seeks FDA premarket approval for ALK IHC companion diagnostic to benefit lung cancer... Jan 21 2015
Evotec Signs New Deal for Addictive Disorder Therapies - Analyst Blog Jan 20 2015
Roche to Acquire French Biotechnology Company Trophos - Analyst Blog Jan 19 2015
Amgen (AMGN) Reveals Mixed Results from Vectibix Studies - Analyst Blog Jan 16 2015
Watchmakers Caught In The #Francogeddon Storm Jan 16 2015
A First in North America: CDL Laboratories acquire the latest technology in laboratory analysis from... Jan 15 2015
Own Swiss ADRs? It's better to be lucky than good Jan 15 2015
Swiss ADRs Rise as Franc Surges Jan 15 2015
Why Transparency And Data Sharing In Clinical Trials Matters Jan 15 2015
European Stocks Trade Mixed After Switzerland Scraps Euro Exchange Cap Jan 15 2015
Roche to Acquire Up to 56% Interest in Foundation Medicine - Analyst Blog Jan 14 2015
AstraZeneca Inks Immuno-Oncology Agreement with Omnis - Analyst Blog Jan 14 2015
European Stocks Rise as Retailer Gains Offset Slumping Energy Stocks Jan 13 2015
JPMorgan Healthcare Conference: Big News From Bristol, Shire & Celgene Jan 12 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Steve.dunfield@google
ReplySteve.dunfield@google - 9 months ago
Adjust for split?


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK